GENE ONLINE|News &
America’s Ongoing Battle For Lower Insulin Prices
The cost of healthcare in America is astronomical, and insulin prices are a heavy burden on millions of Americans each month. In March, the U.S. House of Representatives passed the Affordable Insulin Now Act to cap insulin prices for insured individuals to $35 a month. The bill appears optimistic for people with diabetes, but the text raises questions about who will actually benefit from lower insulin prices and who may have to pay the same as they have been.
Why Insulin Is A Focal Point For Legislation
Insulin is used to treat diabetes by helping blood sugar enter the body’s cells to create energy. It also signals the liver to store blood sugar for later use, which helps regulate normal organ function. Without insulin, patients with diabetes can develop problems like heart disease, vision loss, and kidney disease.
GO Prime with only $1.49 now
LATEST
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
Retired DEA Judge John Mulrooney and Attorney Andrew Hull to Present on Controlled Substances at January 2026 ACI Summit
2026-01-12
Thermal Cycloaddition Achieves Synthesis of Gem-Difluoro Bicycloalkanes for Medicinal Chemistry
2026-01-12
Study Explores Gene Expression Changes in Freeze-Tolerant Vertebrates During Subzero Conditions
2026-01-12
Study Explores Water-Use Efficiency and Heat Tolerance in Lasiurus sindicus for Survival in Arid Ecosystems
2026-01-12
